Document is current
Any future updates will be listed below
-
Authors
Colón-Emeric, Cathleen S. https://orcid.org/0000-0001-7681-8624
Hecker, Emily J.
McConnell, Eleanor
Herndon, Laurie
Little, Milta
Xue, Tingzhong
Berry, Sarah
-
Funding
Funding for this research was provided by:
national institute on aging (AG062492-01)
- License Information
-
More Information
Article History
Received: 20 July 2021
Accepted: 16 December 2021
First Online: 3 January 2022
Declarations
:
: All study procedures were approved by the Advarra Institutional Review Board (central IRB, Hebrew Senior Life) and the Duke University School of Medicine IRB.
: Verbal informed consent was obtained from all participants under a waiver or documentation of informed consent and HIPAA authorization.
: All authors agree to publication of this manuscript.
: In the past 5 years, CCE has received funding from Amgen and UCB as endpoint adjudication chair and as Data Safety Monitoring Chair for Novartis for drugs related to treatment of osteoporosis or osteosarcopenia. SB received research funding from Amgen. No other authors have any conflict of interest with this analysis.
